Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

New COOs for Vividion, Edgewise

Plus: Pacira names new heads of commercial, CBO and updates from Vib spinout Tanai, Arcus, Kyverna and Alx 

January 23, 2025 2:13 AM UTC

Vividion Therapeutics Inc. promoted Jean Bemis, who joined the precision cancer and immune disorders unit of Bayer AG (Xetra:BAYN) in 2017, to COO from SVP of R&D operations and alliances.

Edgewise Therapeutics Inc. (NASDAQ:EWTX) also named a new COO, promoting Behrad Derakhshan from CBO. Additionally, the skeletal and cardiac muscle diseases company named Robert Blaustein chief development officer. Blaustein was an associate VP at Merck & Co. Inc. (NYSE:MRK). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article